Massachusetts General Hospital’s Post

The LeviCell® EOS system has officially been installed at Mayo Clinic's brand-new Integrated Education and Research Building (IERB) in Phoenix! This state-of-the-art addition to Mayo Clinic's shared resource lab will empower researchers across multiple labs and departments on campus with advanced cell enrichment and sample prep capabilities. 💡🔬 Our on-site seminar and hands-on training, presented by Jason McKinney and Cole Jones (he/him) were a resounding success, and included Principal Investigators, senior scientists, post-docs, and lab technicians, all eager to explore the power of Levitation Technology™. The training sessions were a fantastic opportunity to showcase how the EOS system is transforming workflows and driving innovation in research. 🙌 Here's to advancing science together at Mayo Clinic! 🥂✨ Don't get left behind - your research deserves the very best sample prep and cell enrichment. Visit https://bit.ly/3OGgY5l to learn more about the LeviCell EOS system. #LevitasBio #LeviCellEOS #MayoClinicResearch #LevitationTechnology #ScientificInnovation

🌟Harnessing the power of scientific collaboration to drive life-changing innovations for the CF community! 🌟 We are thrilled to announce that we’ve awarded $859,932 in our ✨first ever ✨Collaborative Research Grant to researchers at University of Iowa Roy J. and Lucille A. Carver College of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, and University of Rochester School of Medicine and Dentistry to support their important work focused on improving how CF therapeutics are delivered effectively to airway cells. Led by Paul McCray, MD, Beverly Davison, PhD, and John Lueck, PhD, this groundbreaking project will use advanced AAV capsid variants to develop targeted therapies for people with #CysticFibrosis. We are incredibly proud to support this cutting-edge research that holds the potential to provide curative treatments for all people with CF, including those in the final 10% who do not benefit from current therapies. Learn more: https://bit.ly/3KlYdlq #CureCF #RearchGrants #CysticFibrosisResearch #CFresearch

This is optimal.

Check out this amazing paper by microbiome expert Keaton Stagaman! This research is a tour de force in the oral and gut microbiome in Parkinson's disease; a must read!

Can't wait to team up with Ohio Women in Government & G2G - Innovative Government Affairs Consulting to educate, empower and network with #women in #Ohio! We will have a great opportunity to keep building this OWIG community of talented professionals in government affairs while learning about what is key---life-saving---when it comes to breast cancer and early detection. Did you know that when caught early, #breastcancer is ~99% survivable! 99%!!! But we are not enabling ALL women to achieve this by using technology that doesn't detect cancer in women with dense breasts. This is unacceptable, especially when the physicians, technology and resources are right under our nose to dramatically decrease late stage detection. Join us October 8 to learn more and become an advocate for change! Self-advocacy, advocacy for your loved ones, and advocacy in the public sphere are ALL needed. Let's do this! #womenshealth #policy

I'm thrilled to share that Performance Vision Technologies Inc. (PVTI) is supporting an innovative clinical trial at the University of Alabama at Birmingham (UAB) School of Optometry using our ALTIUS® Amber single-use contact lenses. This NIH/NEI-funded study, "Development of a Novel, Wavelength-Based Intervention for Controlling Childhood Myopia," is a placebo-controlled, randomized clinical trial investigating a potential breakthrough in managing childhood myopia. Following highly encouraging preclinical results, this research could introduce a new paradigm in myopia management - addressing a condition projected to affect 40% of the global population by 2050. We’re honored to support this vital research led by Dr. Safal Khanal and team at UAB School of Optometry, an institution at the forefront of vision research and clinical practice. If you'd like to learn more:  Study Contact: skhanal@uab.edu | 205-934-4558

Our latest publication

This article reeks of gaslighting by the CIRM board/administrators, and the media promoters of a scientific ideology that needs to be overturned. Worse, it does disservice to the people of California, and the United States. A major shift in the seeking and servicing (providing needed resource allocations) of alternative scientific hypotheses is actually needed, and will likely be happening. Many, in hushed tones, have argued that an upper escholon of the influential scientists and administrators have had an unprecedented privilege to form illusory and artificial scientific consensus at the local, state, and National levels. This heavy handed privileging is what has led to a significant misrepresentation of what the process of science is, and how it should dictate policy. Yamamoto and Melmed have been very effective mouthpieces for the maintenance of such privileging, and for the steering tens of billions of dollars toward flawed science and false claims. Hiltzik has been a highly effective media promoter for the same, and now has a national reputation for a leading a gaslighting campaign for a process gone awry. And we, the people, have both unwittingly or intentionally supported the privatization of the public entities (non-profit Universities) and healthcare corporations), and have enabled their appointed (not earned) leadership in the promotion of a false consensus science, as opposed to competitive science. A swing in the see-saw is needed to restore balance. Even if it comes from a bruined former presidential candidate with good intentions.

The Wound Healing Foundation has partnered with the Integra Foundation to award three wound preceptorship grants to aspiring wound healing research scientists. These $2,000 grants will allow for each recipient to visit a nationally recognized wound care center, where they will generate a better understanding of wound healing clinical care and research and network with other wound experts. Read more about the Wound Healing Foundation - Integra Foundation Preceptorship Program https://lnkd.in/gQpEcBJ9

Check out this great work by Virginia Fregona on the Impact of Thrombus Composition on Thrombectomy Procedures for Ischemic Stroke Patients! A collaborative effort between Politecnico di Milano, Delft University of Technology, and Erasmus MC within the framework of our DTH-GEMINI project. #DigitalTwin #StrokeResearch #Thrombectomy